Roberto Bernardoni
Overview
Explore the profile of Roberto Bernardoni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
244
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ciampelli C, Galleri G, Galioto M, Mereu P, Pirastru M, Bernardoni R, et al.
Int J Mol Sci
. 2025 Mar;
26(5).
PMID: 40076730
Parkinson's disease (PD) is a fatal neurodegenerative disease for which there are no still effective treatments able to stop or slow down neurodegeneration. To date, pathological mutations in the leucine-rich...
2.
Nguyen H, Galleri G, Rassu A, Ciampelli C, Bernardoni R, Galioto M, et al.
Biomedicines
. 2024 Jul;
12(7).
PMID: 39062128
Pathological mutations in the gene are the major genetic cause of Parkinson's disease (PD). Although several animal models with either LRRK2 down- or over-expression have been developed, the physiological function...
3.
Ciampelli C, Galleri G, Puggioni S, Fais M, Iannotta L, Galioto M, et al.
Int J Mol Sci
. 2023 Aug;
24(16).
PMID: 37628835
Pathological mutations in leucine-rich repeat kinase 2 (LRRK2) gene are the major genetic cause of Parkinson's disease (PD). Multiple lines of evidence link LRRK2 to the control of vesicle dynamics...
4.
Messelodi D, Strocchi S, Bertuccio S, Baden P, Indio V, Giorgi F, et al.
Commun Biol
. 2023 Apr;
6(1):431.
PMID: 37076591
Gaucher Disease (GD), the most common lysosomal disorder, arises from mutations in the GBA1 gene and is characterized by a wide spectrum of phenotypes, ranging from mild hematological and visceral...
5.
Bernardoni R, Giordani G, Signorino E, Monticelli S, Messa F, Pradotto M, et al.
Haematologica
. 2018 Nov;
104(4):717-728.
PMID: 30409797
The oncoprotein BCR-ABL1 triggers chronic myeloid leukemia. It is clear that the disease relies on constitutive BCR-ABL1 kinase activity, but not all the interactors and regulators of the oncoprotein are...
6.
Ferrucci F, Ciaccio R, Monticelli S, Pigini P, Di Giacomo S, Purgato S, et al.
Biochim Biophys Acta Gene Regul Mech
. 2018 Feb;
1861(3):235-245.
PMID: 29408445
Childhood neuroblastoma, a disease of the sympathetic nervous system, is the most common solid tumour of infancy, remarkably refractory to therapeutic treatments. One of the most powerful independent prognostic indicators...
7.
Giordani G, Barraco M, Giangrande A, Martinelli G, Guadagnuolo V, Simonetti G, et al.
Oncotarget
. 2016 Aug;
7(34):55313-55327.
PMID: 27486815
The efficient treatment of hematological malignancies as Acute Myeloid Leukemia, myelofibrosis and Chronic Myeloid Leukemia, requires the elimination of cancer-initiating cells and the prevention of disease relapse through targeting pathways...
8.
Popkova A, Bernardoni R, Diebold C, Van De Bor V, Schuettengruber B, Gonzalez I, et al.
PLoS Genet
. 2013 Jan;
8(12):e1003159.
PMID: 23300465
The Gcm/Glide transcription factor is transiently expressed and required in the Drosophila nervous system. Threshold Gcm/Glide levels control the glial versus neuronal fate choice, and its perdurance triggers excessive gliogenesis,...
9.
Universal neonatal screening for sickle cell disease and other haemoglobinopathies in Ferrara, Italy
Ballardini E, Tarocco A, Marsella M, Bernardoni R, Carandina G, Melandri C, et al.
Blood Transfus
. 2012 Oct;
11(2):245-9.
PMID: 23058858
Background: Sickle cell disease is the commonest haemoglobinopathy in Africa, the Middle East and India. In recent years, its incidence has increased dramatically also in Europe and North America because...
10.
Porro A, Iraci N, Soverini S, Diolaiti D, Gherardi S, Terragna C, et al.
Mol Cancer Res
. 2011 Jun;
9(8):1054-66.
PMID: 21693596
Resistance to chemotherapeutic agents remains one of the major impediments to a successful treatment of chronic myeloid leukemia (CML). Misregulation of the activity of a specific group of ATP-binding cassette...